Guangdong Marubi Biotechnology Co Tangible Net Worth Ratio
Guangdong Marubi Biotechnology Co tangible net worth ratio. Guangdong Marubi Biotechnology Co (603983) has a Tangible Net Worth Ratio of 88.7% as of June 2026. This metric is calculated by deducting intangible assets (CN¥387.85 Million) from net assets (CN¥3.44 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Guangdong Marubi Biotechnology Co equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Guangdong Marubi Biotechnology Co (2011–2025)
Tangible net worth ratio of Guangdong Marubi Biotechnology Co from 2011 to 2025. This chart shows how Guangdong Marubi Biotechnology Co's Tangible Net Worth Ratio has changed across 15 annual periods from 2011 to 2025. As of June 2026, the ratio stands at 88.7%, reflecting net assets of CN¥3.44 Billion with intangible assets of CN¥387.85 Million CNY. Check how strategically is Guangdong Marubi Biotechnology Co's equity deployed to assess the company's strategic physical and investment asset allocation.
Guangdong Marubi Biotechnology Co Tangible Net Worth Ratio by Year (2011–2025)
Guangdong Marubi Biotechnology Co tangible net worth ratio by year from 2011 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Guangdong Marubi Biotechnology Co from 2011 to 2025, covering 15 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Guangdong Marubi Biotechnology Co (603983) total market value.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 88.4% | CN¥3.39 Billion | CN¥394.15 Million | CN¥4.61 Billion | ▲ +8.7 pp |
| 2024 | 79.7% | CN¥3.45 Billion | CN¥699.16 Million | CN¥5.06 Billion | ▲ +0.8 pp |
| 2023 | 79.0% | CN¥3.42 Billion | CN¥719.58 Million | CN¥4.45 Billion | ▲ +2.0 pp |
| 2022 | 77.0% | CN¥3.25 Billion | CN¥748.63 Million | CN¥4.09 Billion | ▲ +1.2 pp |
| 2021 | 75.8% | CN¥3.16 Billion | CN¥764.56 Million | CN¥3.76 Billion | ▼ -23.6 pp |
| 2020 | 99.4% | CN¥3.00 Billion | CN¥18.63 Million | CN¥3.80 Billion | ▲ +0.0 pp |
| 2019 | 99.3% | CN¥2.67 Billion | CN¥17.74 Million | CN¥3.44 Billion | ▲ +1.3 pp |
| 2018 | 98.0% | CN¥1.38 Billion | CN¥27.64 Million | CN¥2.12 Billion | ▼ -0.1 pp |
| 2017 | 98.1% | CN¥959.96 Million | CN¥17.78 Million | CN¥1.60 Billion | ▲ +0.3 pp |
| 2016 | 97.9% | CN¥828.09 Million | CN¥17.44 Million | CN¥1.48 Billion | ▼ -0.2 pp |
| 2015 | 98.1% | CN¥715.92 Million | CN¥13.85 Million | CN¥1.37 Billion | ▲ +0.1 pp |
| 2014 | 98.0% | CN¥604.48 Million | CN¥12.30 Million | CN¥1.20 Billion | ▲ +0.7 pp |
| 2013 | 97.3% | CN¥453.11 Million | CN¥12.18 Million | CN¥939.25 Million | ▲ +4.4 pp |
| 2012 | 92.9% | CN¥234.87 Million | CN¥16.68 Million | CN¥704.69 Million | ▲ +4.8 pp |
| 2011 | 88.1% | CN¥148.02 Million | CN¥17.63 Million | CN¥596.96 Million | — |